Atea Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Atea Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Atea Pharmaceuticals Inc
Rating: 1.62008325
Author: Trendlyne DVM scores

about

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvi...

4.36 0.04 (0.93%)

32.40% Fall from 52W High

232.3K

XNAS Volume

XNAS 09 Jun, 2026 4:00 PM (EDT)

Board Meeting

The next board meeting for Atea Pharma Inc is on 19 Jun 2026 for the purpose of Atea Pharmaceuticals Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

11.3 / 100

Technically Neutral

53.5 / 100

No estimates available

Atea Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Atea Pharma Inc Live Stock Price Today, Share Analysis and Chart

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvi...

32.40% Fall from 52W High

SWOT Analysis

Atea Pharma Inc Live Price Chart